The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 Selectively Potentiates sorted by
relevance

Admin19.08.2021

The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 Selectively Potentiates

8900
Admin17.07.2021

The Epidermal Growth Factor Receptor Tyrosine Kinase

8205
Admin08.08.2021

(PDF) ZD1839 (Iressa), a specific oral epidermal growth

8307
Admin29.08.2021

(PDF) Gefitinib (Iressa, ZD1839), an Epidermal Growth

9305
Admin15.07.2021

The Epidermal Growth Factor Receptor Tyrosine Kinase

3100
Admin02.10.2021

(PDF) Gefitinib (Iressa, ZD1839), a selective epidermal

2907
Admin03.10.2021

ZD1839, a Selective Epidermal Growth Factor Receptor

4109
Admin15.07.2021

(PDF) Inhibition of Proliferation, Migration, and Matrix

3900
Admin04.10.2021

Enhancement of Antitumor Activity of Ionizing Radiation by

8901
Admin21.07.2021

(PDF) Gefitinib (Iressa, ZD1839), a selective epidermal

7101
Admin21.07.2021

Enhancement of Antitumor Activity of Ionizing Radiation by

7706
Admin09.09.2021

(PDF) ZD1839 (Iressa), a specific oral epidermal growth

4503
Admin03.10.2021

(PDF) Gefitinib (Iressa, ZD1839), a selective epidermal

8207
Admin20.08.2021

Enhancement of Antitumor Activity of Ionizing Radiation by

4203
Admin01.09.2021

(PDF) ZD1839 (Iressa), a specific oral epidermal growth

6105
Admin24.07.2021

The Epidermal Growth Factor Receptor Tyrosine Kinase

405
Admin09.09.2021

ZD1839, a Selective Epidermal Growth Factor Receptor

2208
Admin24.08.2021

Tyrosine Kinase Inhibitors: Synthesis of Gefinitib

26010
Admin17.09.2021

(PDF) Gefitinib (Iressa, ZD1839), a selective epidermal

2008
Admin08.09.2021

Influence of epidermal growth factor receptor (EGFR), p53

2703
Admin10.08.2021

The Epidermal Growth Factor Receptor Tyrosine Kinase